Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of July 31, 2026
Press Release VELIZY-VILLACOUBLAY, France – August 7, 2026 Declaration of the number of outstanding shares and voting…
Alaska Airlines Boeing 787-9 is declaring an emergency off France coast, after U-turn over UK
An Alaska Airlines Boeing 787-9 Dreamliner (registration N780HA) has declared an emergency over the Atlantic Ocean after reversing…
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following…
Airbus says global air traffic will double in 20 years, as aircraft backlog presents challenge for NZ
She said worldwide, airlines generally had more focus now on fleet expansion, which meant airlines would be operating…
Hermès International: Situation of the liquidity contract as of June 30, 2026
Get the latest news delivered to your inbox Sign up for The Manila Times newsletters…
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of June 30, 2026
Press Release VELIZY-VILLACOUBLAY, France – July 6, 2026 Declaration of the number of outstanding shares and voting…
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without…
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
Sanofi appoints Paulo Fontoura as Global Head of R&D Paris, June 22, 2026. Sanofi today announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of…
France Lauds Iran-US MoU as Important Step Toward Lasting Peace
Islam Times – French President Emmanuel Macron welcomed the signing of the Iran-US Memorandum of Understanding, describing it…
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3…
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of May 31, 2026
Press Release VELIZY-VILLACOUBLAY, France – June 8, 2026 Declaration of the number of outstanding shares and voting…
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Announcement at EHA 2026
New Spherix Global Insights research finds no clear standard of care beyond second line, creating an opportunity for…